298 related articles for article (PubMed ID: 26824183)
1. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
Soriano A; París-Coderch L; Jubierre L; Martínez A; Zhou X; Piskareva O; Bray I; Vidal I; Almazán-Moga A; Molist C; Roma J; Bayascas JR; Casanovas O; Stallings RL; Sánchez de Toledo J; Gallego S; Segura MF
Oncotarget; 2016 Feb; 7(8):9271-87. PubMed ID: 26824183
[TBL] [Abstract][Full Text] [Related]
2. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis
Zhao J; Zhou K; Ma L; Zhang H
Bioengineered; 2020 Dec; 11(1):219-228. PubMed ID: 32083506
[TBL] [Abstract][Full Text] [Related]
7. microRNA-1228
Jia L; Chen J; Xie C; Shao L; Xu Z; Zhang L
Life Sci; 2017 Jul; 180():9-16. PubMed ID: 28465246
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
Wang Z; Lei H; Sun Q
Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
[TBL] [Abstract][Full Text] [Related]
10. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
[TBL] [Abstract][Full Text] [Related]
11. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
[TBL] [Abstract][Full Text] [Related]
12. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
[TBL] [Abstract][Full Text] [Related]
13. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM
Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116
[TBL] [Abstract][Full Text] [Related]
14. miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1.
Chen S; Jin L; Nie S; Han L; Lu N; Zhou Y
Oncol Res; 2018 Apr; 26(3):445-455. PubMed ID: 28653600
[TBL] [Abstract][Full Text] [Related]
15. microRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7.
Cao XY; Sun ZY; Zhang LJ; Chen MK; Yuan B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):716-723. PubMed ID: 30720179
[TBL] [Abstract][Full Text] [Related]
16. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Zhang H; Qi M; Li S; Qi T; Mei H; Huang K; Zheng L; Tong Q
Mol Cancer Ther; 2012 Jul; 11(7):1454-66. PubMed ID: 22564723
[TBL] [Abstract][Full Text] [Related]
17. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
Li J; Hu L; Tian C; Lu F; Wu J; Liu L
BMC Mol Biol; 2015 Dec; 16():24. PubMed ID: 26715362
[TBL] [Abstract][Full Text] [Related]
18. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
Li Y; Wang H; Li J; Yue W
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):48-55. PubMed ID: 24345480
[TBL] [Abstract][Full Text] [Related]
19. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
[TBL] [Abstract][Full Text] [Related]
20. microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.
He XY; Tan ZL; Mou Q; Liu FJ; Liu S; Yu CW; Zhu J; Lv LY; Zhang J; Wang S; Bao LM; Peng B; Zhao H; Zou L
Clin Cancer Res; 2017 Jun; 23(11):2905-2918. PubMed ID: 28003306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
